OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
Trial details
- Registry ID
- NCT04314934
- Drugs studied
- ANAVEX2-73
TrialRedline tracks 3 clinical trials sponsored by Anavex Life Sciences Corp.: 2 Phase 2 / 3, 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| OLE of Phase 2b/3 Study ANAVEX2-73-AD-004NCT04314934 | ANAVEX2-73 | Completed | 2024-06-14Actual |
| ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeNCT04304482 | ANAVEX2-73 oral liquid | Completed | 2023-06-01Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of ANAVEX3-71 in Adults With SchizophreniaNCT06245213 | ANAVEX3-71 oral capsules | Active not recruiting | 2025-06-30Estimated |
Names as written in the registry records.